Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma for prevention of secondary infection in high-risk critically ill ICU patients
ISRCTN10449048Phase 2Recruiting
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial in Healthcare-associated infection (HAI) comparing Interferon gamma with Placebo (2 arms). Primary endpoint: Antibiotic-free days over 14 days. Started Apr 2024; status: recruiting.
02
Drugs
interferon gamma-1b
03
Conditions
Healthcare-associated infection (HAI)
Beyond the preview
Go deeper on ISRCTN10449048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10449048.